VLS.AX ASX
Vita Life Sciences Limited
1W: +0.0%
1M: -0.4%
3M: +12.7%
YTD: +6.2%
1Y: +22.1%
3Y: +95.7%
5Y: +168.0%
A$2.71 ($1.88)
-0.05 (-1.81%)
Weekly Expected Move ±1.8%
A$3
A$3
A$3
A$3
A$3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$82M
+14.6% ▲
5Y CAGR: +16.1%
Total Liabilities
$26M
+33.6% ▲
5Y CAGR: +12.3%
Shareholders Equity
$56M
+7.4% ▲
5Y CAGR: +17.9%
Cash & Investments
$36M
+24.3% ▲
5Y CAGR: +19.7%
Total Debt
$4M
+732.5% ▲
5Y CAGR: +15.7%
Net Debt
-$31M
-11.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $16M | $16M | $25M | $29M | $36M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $16M | $16M | $25M | $29M | $36M |
| Net Receivables | $7M | $9M | $11M | $12M | $14M |
| Inventory | $11M | $15M | $11M | $17M | $15M |
| Other Current Assets | $306K | $473K | $704K | $931K | $879K |
| Total Current Assets | $35M | $41M | $48M | $59M | $66M |
| Property, Plant & Equip. | $8M | $8M | $9M | $10M | $12M |
| Goodwill & Intangibles | $0 | $10K | $26K | $50K | $36K |
| Long-Term Investments | $0 | -$2M | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $2M | $0 | $0 | $0 |
| Total Non-Current Assets | $10M | $11M | $12M | $13M | $17M |
| Total Assets | $45M | $52M | $60M | $72M | $82M |
| — Liabilities — | |||||
| Accounts Payable | $4M | $4M | $6M | $6M | $7M |
| Short-Term Debt | $190K | $300K | $211K | $0 | $482K |
| Deferred Revenue | $7M | $4M | $4M | $0 | $6M |
| Other Current Liabilities | $7K | $4M | $4M | $11M | $6M |
| Total Current Liabilities | $14M | $15M | $16M | $19M | $24M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $2M |
| Other Non-Current Liab. | $132K | $135K | $84K | $121K | -$2M |
| Total Non-Current Liabilities | $386K | $436K | $260K | $335K | $2M |
| Total Liabilities | $15M | $15M | $16M | $20M | $26M |
| — Equity — | |||||
| Common Stock | $42M | $42M | $43M | $45M | $43M |
| Retained Earnings | -$13M | -$8M | -$3M | $846K | $5M |
| Accumulated OCI | $2M | $3M | $4M | $6M | $7M |
| Total Stockholders Equity | $31M | $37M | $43M | $52M | $56M |
| Total Liabilities & Equity | $45M | $52M | $60M | $72M | $82M |
| — Key Metrics — | |||||
| Total Debt | $373K | $601K | $387K | $517K | $4M |
| Net Debt | -$16M | -$15M | -$24M | -$28M | -$31M |
| Total Investments | $0 | -$2M | $0 | $0 | $0 |